Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis

P D Home, S J Pocock, H Beck-Nielsen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Udgivelsesdato: 2007-Dec
OriginalsprogEngelsk
TidsskriftEvidence - Based Medicine
Vol/bind12
Udgave nummer6
Sider (fra-til)170
ISSN2515-446X
DOI
StatusUdgivet - 1. dec. 2007

Citer dette

@article{4b275290cb5111dc8674000ea68e967b,
title = "Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis",
abstract = "Udgivelsesdato: 2007-Dec",
author = "Home, {P D} and Pocock, {S J} and H Beck-Nielsen",
year = "2007",
month = "12",
day = "1",
doi = "10.1136/ebm.12.6.170",
language = "English",
volume = "12",
pages = "170",
journal = "BMJ Evidence-Based Medicine",
issn = "2515-446X",
publisher = "BMJ Group",
number = "6",

}

Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis. / Home, P D; Pocock, S J; Beck-Nielsen, H.

I: Evidence - Based Medicine, Bind 12, Nr. 6, 01.12.2007, s. 170.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis

AU - Home, P D

AU - Pocock, S J

AU - Beck-Nielsen, H

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Udgivelsesdato: 2007-Dec

AB - Udgivelsesdato: 2007-Dec

U2 - 10.1136/ebm.12.6.170

DO - 10.1136/ebm.12.6.170

M3 - Journal article

VL - 12

SP - 170

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

SN - 2515-446X

IS - 6

ER -